MAPK7 and neoplasm: The T. serpyllum L. EO has demonstrated inhibitory effects on oral cancer cells via the modulation of multiple tumor-suppressive signaling pathways, including interferon signaling, N-glycan biosynthesis, and extracellular signal-regulated kinase 5 (ERK5) pathways [92].